Acadia Pharmaceuticals ACAD Net Change in Cash
Net Change in Cash at other companies
Other financials
Where this comes from
Reported directly by Acadia Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect.
The official record: Acadia Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Acadia Pharmaceuticals's net change in cash.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Acadia Pharmaceuticals's net change in cash?
- Acadia Pharmaceuticals (ACAD) reported net change in cash of $104.52M in Q1 2026.
- How has Acadia Pharmaceuticals's net change in cash changed year-over-year?
- Acadia Pharmaceuticals's net change in cash increased by 202.6% year-over-year, from -$101.89M to $104.52M.
- What is the long-term trend for Acadia Pharmaceuticals's net change in cash?
- Over 2 years (2022 to 2024), Acadia Pharmaceuticals's net change in cash has grown at a 102.7% compound annual growth rate (CAGR), from -$32.59M to $133.93M.
- What does net change in cash mean?
- Total increase or decrease in cash during the period — the sum of operating, investing, financing cash flows plus FX effects.